Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2001
10/04/2001WO2001072323A2 Use of insulin for the treatment of cartilagenous disorders
10/04/2001WO2001072295A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/04/2001WO2001072132A1 Non-human transgenic animals expressing platelet-derived growth factor c (pdgf-c) and uses thereof
10/04/2001WO2001072119A2 Non-human animal model for growth deficiency and information processing or cognitive function defects and use thereof
10/04/2001WO2001040274A3 Inhibition of hrsv membrane fusion
10/04/2001WO2001036657A3 Altered type ix collagen gene sequences associated with intervertebral disc disease
10/04/2001WO2001036638A8 Polypeptides and nucleic acids encoding same
10/04/2001WO2001036456A3 Chlamydia antigens and corresponding dna fragments and uses thereof
10/04/2001WO2001023563A3 Compositions and therapeutic methods using morphogenic proteins, hormones and hormone receptors
10/04/2001WO2001023523A3 Secreted proteins and uses thereof
10/04/2001WO2001021784A3 Pcna-associated cell cycle proteins, compositions and methods of use
10/04/2001WO2001021644A3 Wheat dp proteins and uses thereof
10/04/2001WO2001019862A3 Polypeptides from moraxella (branhamella) catarrhalis
10/04/2001WO2001018208A3 Interferon induced polynucleotides and proteins encoded thereby
10/04/2001WO2001016319A3 Compositions and methods for the treatment of immune related diseases
10/04/2001WO2001011047A3 Dna sequences isolated from human colonic epithelial cells
10/04/2001WO2001009150A3 Compositions and methods to enhance sensitivity of cancer cells to mitotic stress
10/04/2001WO2000071564A8 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
10/04/2001WO2000062795A9 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS
10/04/2001WO2000048622A9 Method for inhibiting inflammatory responses
10/04/2001WO2000043039A9 Vaccine-mediated treatment of neurological disorders
10/04/2001WO2000042189A9 Interleukin-20
10/04/2001WO2000040695A9 Sequence-determined dna fragments and corresponding polypeptides encoded thereby
10/04/2001WO2000039310A9 Rubredoxin fusion proteins, protein expression system and methods
10/04/2001WO2000039279A9 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/04/2001WO2000012708A3 Further pro polypeptides and sequences thereof
10/04/2001WO1999055860A8 Host-encoded protein expressed on marek's disease (mdv)-infected cells and antibody thereto
10/04/2001WO1999046387A9 Biosynthetic genes for spinosyn insecticide production
10/04/2001US20010027567 DNA molecule encoding recombinatorial substrate and reporter gene; activation by recombinase to effect gain or loss of gene function; transgenic mammal with said DNA; identification of transgene by phenotype of reporter gene
10/04/2001US20010027566 Transgenic animal model of basal cell carcinoma
10/04/2001US20010027565 Capable of binding envelope protein of hepatitis virus; therapy and/or diagnostic tool for hepatitis infection
10/04/2001US20010027249 Chimeric antibody comprising human immunoglobin constant region and murine variable region
10/04/2001US20010027248 Obtained from rat forebrain; characterized by binding affinity for trans-(+)-6-acetyl-4S-(4-fluorobenzolamino) -3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-3R-ol; therapy and prophylaxis of neurological disorders and/or drug withdrawal
10/04/2001US20010027179 Antibodies against analogs of brain-derived neurotrophic factor
10/04/2001US20010027174 Polypeptides containing neo-tryptophan; neurotensin analogs; neotryptophan derivatives; method of synthesis starting from 2-methyl-3-nitrobenzoic acid; administering to a mammal having a serotonin recognition molecule
10/04/2001US20010026940 Biopesticides
10/04/2001US20010026939 Comprising a chimeric gene that expresses a polypeptide having insect toxicity properties of Bacillus thuringiensis crystal protein
10/04/2001US20010026931 Accelerates differentiation of megakaryocytes in the presence of IL-3, and acts as a thrombopoietin, and therefore an effective medicament to various diseases involving a decrease in platelets
10/04/2001US20010026930 Isolating mutant yeast cells with an increased life span by exposing sample of yeast cells from budding yeast strain, for which the life span is known, to a mutagen, plating, replica-plating, culturing
10/04/2001US20010026927 Compounds or surface active agents with a phosphorylcholine group and another cationic group, and an antibody to the protein; without dilution while avoiding prozone phenomenon
10/04/2001US20010026926 A target receptor protein whose signal transduction activity can be modulated by interaction with an extracellular signal, and an expressible recombinant gene encoding an exogenous test polypeptide from a polypeptide library; rapid, reliable
10/04/2001US20010026799 Genome with mutation expresses native immediate early gene from genome with delayed kinetics; gene therapy
10/04/2001US20010026795 Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system
10/04/2001EP1144629A3 Further pro polypeptides and sequences thereof
10/04/2001EP1138786A2 Specific and universal amplification primers to rapidly detect and identify common bacterial pathogens and antibiotic resistance genes from clinical specimens for routine diagnosis in microbiology laboratories
10/04/2001EP1138781A2 Method for Quantifying DNA binding activity of DNA binding proteins
10/04/2001EP1138774A2 Defective recombinant adenoviruses expressing cytokines for use in antitumoral treatement
10/04/2001EP1138773A2 Use of plasmids for the manufacture of a composition for vaccine treatment by human and animal
10/04/2001EP1138772A1 Process for producing apelin
10/04/2001EP1138768A2 Apoptin-associating protein AAP-5
10/04/2001EP1138767A2 Disease resistance in vitis
10/04/2001EP1138766A2 Process for preparing major histocompatibility antigen class II protein and materials having the same immobilized thereon
10/04/2001EP1138765A1 Apoptin-associating proteins AAP-5 and AAP-6
10/04/2001EP1138763A2 Method for generating polynucleotides having desired characteristics by iterative selection and recombination
10/04/2001EP1138694A1 Hirulog-like peptide
10/04/2001EP1138693A1 Novel g protein-coupled receptor protein and dna thereof
10/04/2001EP1138692A1 Fragments of human chorionic gonadotropin (hcg) as immunoregulator
10/04/2001EP1137941A1 Protein scaffolds for antibody mimics and other binding proteins
10/04/2001EP1137940A1 Assays for ligands for nuclear receptors
10/04/2001EP1137812A1 Dna-protein fusions and uses thereof
10/04/2001EP1137810A2 A$g(b)-PEPTIDE SCREENING ASSAY
10/04/2001EP1137797A1 Expression system for factor viii
10/04/2001EP1137792A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof
10/04/2001EP1137791A2 Regulatory sequences of the mouse villin gene - use in transgenesis
10/04/2001EP1137789A1 A method for manufacturing glycoproteins having human-type glycosylation
10/04/2001EP1137787A1 Enhanced protein production in higher plants by n-terminal fusion of a ubiquitin or a cucumber mosaic virus coat protein peptide
10/04/2001EP1137786A1 Virus coat protein/receptor chimeras and methods of use
10/04/2001EP1137780A1 Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp
10/04/2001EP1137779A2 Identification of senv genotypes
10/04/2001EP1137778A1 Polypeptides and polynucleotides "basb040" from neisseria meningitidis and vaccine comprising said polypeptides and polynucleotides
10/04/2001EP1137777A2 Novel compounds derived from neisseria meningitidis
10/04/2001EP1137776A2 Non-endogenous, constitutively activated human g protein-coupled receptors
10/04/2001EP1137775A1 htfIIIA HUMAN GENE AND CODED hTFIIIA PROTEIN
10/04/2001EP1137774A2 Grnf4, a gdnf-related neurotrophic factor
10/04/2001EP1137773A2 Growth factor homolog zvegf3
10/04/2001EP1137772A1 Spermatogenesis protein
10/04/2001EP1137771A2 Methods for preventing cardiac hypertrophy and heart failure by inhibition of mef2 transcription factor
10/04/2001EP1137770A2 Heat shock genes and proteins from neisseria meningitidis, candida glabrata and aspergillus fumigatus
10/04/2001EP1137760A1 Bleaching enzymes and detergent compositions comprising them
10/04/2001EP1137759A2 Live attenuated venezuelan equine encephalitis vaccine
10/04/2001EP1137757A1 Dna molecules encoding the melanocortin 5 receptor protein from rhesus monkey
10/04/2001EP1137756A2 Differentiation signal
10/04/2001EP1137754A2 Method for constructing libraries of phenotypic profiles
10/04/2001EP1137668A1 A method for detecting neuronal cell damage by quantification of map-2 levels in biological fluids
10/04/2001EP1137667A2 Analogues of glp-1
10/04/2001EP1137666A1 Glp-1 analogues
10/04/2001EP1137664A2 Protein transduction system and methods of use thereof
10/04/2001EP1137661A1 Procollagen c-proteinase inhibitors
10/04/2001EP1137659A1 Inhibition of angiogenesis by high molecular weight kininogen and peptide analogs thereof
10/04/2001EP1137656A1 31 human secreted proteins
10/04/2001EP1137631A1 REVERSIBLE AQUEOUS pH SENSITIVE LIPIDIZING REAGENTS, COMPOSITIONS AND METHODS OF USE
10/04/2001EP1137436A1 Stimulation of t cells against self antigens using ctla-4 blocking agents
10/04/2001EP1137431A1 Pharmaceutical compositions containing insulin
10/04/2001EP1137418A2 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY
10/04/2001EP1137340A1 Composition and method for regulation of body weight and associated conditions
10/04/2001EP0973800A4 Novel receptor
10/04/2001EP0835309B1 Vaccine for infectious agents, composition for treating and preventing hiv infections
10/04/2001EP0835132B1 Recombinant temperature sensitive mutants of influenza virus
10/04/2001EP0772632B1 T cell stimulating protein of pestivirus
10/04/2001EP0668876B1 Treatment of infertility and enhancement of fertilization capacity in mammalian males by thymosin peptide and its antibodies
1 ... 1957 1958 1959 1960 1961 1962 1963 1964 1965 1966 1967 1968 1969 1970 1971 1972 1973 1974 1975 1976 1977 ... 2916